REQUEST A DEMO
Total
USD $0.00
Search more companies

Wooridul Pharmaceutical Limited (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wooridul Pharmaceutical Limited Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Wooridul Pharmaceutical Limited is engaged in manufacturing of pharmaceutical products. The company offers anti-epileptic agents, anti-inflammatory agents, anti-phlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, respiratory agents, as well as OTC (Over The Counter) drugs such as anti- obesity drugs, health food products and others. Wooridul Pharmaceutical Limited is based in Hwaseong, Gyeonggi-do Province, South Korea. The company was incorporated in 1966 formerly known as Wooridul Life Sciences Limited.

Headquarters
902-5 Pharmaceutical Corporation Hyangnam, Sangsin-Ri, Hyangmam-Myeon, Hwaseong-Si
Hwaseong; Gyeonggi; Postal Code: 445-937

Contact Details: Purchase the Wooridul Pharmaceutical Limited report to view the information.

Website: http://www.wooridulls.co.kr

Basic Information
Total Employees:
Purchase the Wooridul Pharmaceutical Limited report to view the information.
Outstanding Shares:
Purchase the Wooridul Pharmaceutical Limited report to view the information.
Registered Capital:
Purchase the Wooridul Pharmaceutical Limited report to view the information.
Financial Auditors:
Purchase the Wooridul Pharmaceutical Limited report to view the information.
Incorporation Date:
August 22, 1966
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
11.16%
Subsidiaries
(주)디지털수다
(주)에이치케이에셋
(주)엑세스바이오
Company Performance
Financial values in the chart are available after Wooridul Pharmaceutical Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
10.5%
Total operating revenue
-31.26%
Operating profit (EBIT)
-94.02%
EBITDA
-89.32%
Net Profit (Loss) for the Period
-91.83%
Total assets
5.84%
Total equity
10.19%
Operating Profit Margin (ROS)
-59.33%
Net Profit Margin
-42.99%
Return on Equity (ROE)
-31.32%
Debt to Equity Ratio
-2.43%
Quick Ratio
0.45%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?